Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines
Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado's A2B and A2A Receptor Antagonists and Cancer Vaccines Data from studies conducted by investigators at the National Cancer Institute at NCI laboratories, part of a multi-year research effort, will be presented at SITC GlobeNewswire November 07, 2025 Dover, DE, Nov. 07, 2025 (GLOBE NEWSWIRE) […]